In addition to drug treatment, exercise is recommended for treatment of glycemic control in patients with
T2DM, especially for its beneficial effects on blood glucose and HbA1c. Few studies have determined the effects of the
association between exercise and oral glucose-lowering drugs. The study will be conducted to assess the metabolic
and cardiovascular responses at rest, and during and after submaximal exercise in patients receiving one of two oral
glucose-lowering drugs (vildagliptin or glibenclamide).